App-Quantinova.ai

Clinical impact of the use of thrombus aspiration devices in primary angioplasty. Insights from the multicentric study ESTROFA-MI

Jose De la Torre Hernandez - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Outcomes after Anterior ST-Elevation Myocardial Infarction According to LAD Lesion Location: The INFUSE-AMI Trial

Sorin Brener - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

Venous thrombosis

Abciximab

Frequency, Timing and Implications of Reinfarction after Primary Stenting in ST-Segment Elevation Myocardial Infarction: The HORIZONS-AMI trial

Samantha Stone - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Joshua Loh - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

TAXUS

Admission At Nights Or Weekends Has No Adverse Effect On Mortality For ST Elevation Myocardial Infarction Patients Treated By Primary Percutaneous Coronary Intervention: Single Center Study From A Large Tertiary Cardiac Unit In United Kingdom

Refai Showkathali - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

Paclitaxel-eluting Balloon In Primary Percutaneous Coronary Intervention In Amsterdam (PAPPA): Sustained Safety And Efficacy At 12 Months Follow-up

Nicola Vos - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Bivalirudin

Comparison of newer generation drug-eluting stents with bare metal stents in patients with acute ST-segment elevation myocardial infarction: A pooled analysis of EXAMINATION and COMFORTABLE AMI trials

Manel Sabate - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Biolimus A9

Stent Thrombosis after primary PCI for STEMI in relation to non-usage of dual antiplatelet therapy over time: Results of the HORIZONS-AMI trial

Bimmer Claessen - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Aspirin

Chronic Myocardial Tissue Effects of Intracoronary Supersaturated Oxygen in a Porcine Model of Anterior Myocardial Infarction

Greg Kaluza - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Silent Occlusion, But Not Restenosis Without Occlusion After Primary Percutaneous Intervention Strongly Predicts Both Deterioration Of Cardiac Function And Future Clinical Events

Shinichiro Yamada - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

technetium tc 99m tetrofosmin Injection

Small Versus Large Culprit Vessel Size In Primary Percutaneous Coronary Intervention For ST Elevation Myocardial Infarction: Incidence, Clinical Characteristics And Outcome Differences

Refai Showkathali - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

Venous thrombosis

N/A

High Level of Pre-procedural High-Sensitivity C-Reactive Protein Predicts Stent Thrombosis After Percutaneous Coronary Intervention in Patients with Acute Myocardial Infarction

Hae Chang Jeong - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Clinical Syntax Score And Long-Term Outcome After Successful Primary PCI

Andreas Synetos - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

5 types of drug-eluting stents including zotarolimus-eluting stent with biolinx polymer show the similar clinical outcomes for the treatment of ST-segment elevation myocardial infarction

Kyounghoon Lee - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Longitudinal Stent Deformation: Insights On Mechanisms, Treatments and Outcomes From The Food And Drug Administration Manufacturer And User Facility Device Experience Database

Paul Williams - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Predictors of Stent Fracture and Impact on Neointimal Proliferation: Experimental Insights into the Mechanisms of Drug Eluting Stent Failure

Seung-Jin Oh - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Case Series of 100 cases of longitudinal stent Deformation

Doug Fraser - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Umirolimus

The impact of sirolimus-eluting stent and evelolimus-eluting stent on the in-stent restenosis and stent fracture; evaluating peri-stent contrast staining lesions after drug-eluting stent implantation

Tahei Ichinohe - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

sirolimus

Multi-Center, First-In-Man Evaluation of the Myolimus-Eluting Bioresorbable Coronary Scaffold: 6-Month Clinical and Imaging Results

Stefan Verheye - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

N/A

Biodegradable-Polymer Biolimus Eluting Stents Show Better Antiproliferative Efficacy And Vascular Healing Pattern Than Permanent-Polymer Paclitaxel Eluting Stents in a Preclinical Coronary Model

Armando Perez de Prado - Transcatheter Cardiovascular Therapeutics (TCT) , 2012

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

Venous thrombosis

Acetylcholine

Filters

7277 Abstracts